Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Quantum Biopharma Ltd. (V.QNT) had Return on Tangible Equity of 2903.49% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-12.32M |
|
-- |
|
-- |
|
-- |
|
-4.88M |
|
-- |
|
-12.55M |
|
-12.55M |
|
-12.55M |
|
-12.55M |
|
-12.55M |
|
-12.55M |
|
-4.88M |
|
-4.69M |
|
2.48M |
|
2.48M |
|
-5.07 |
|
-5.07 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
21.36M |
|
-- |
|
-- |
|
-- |
|
14.86M |
|
6.50M |
|
-0.43M |
|
6.50M |
|
2.71M |
|
| Cash Flow Statement Financials | |
-6.12M |
|
-1.94M |
|
4.50M |
|
8.61M |
|
5.05M |
|
-3.56M |
|
0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.96 |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-192.97% |
|
|
Return on Tangible Equity |
2903.49% |
-58.76% |
|
-192.97% |
|
2.40 |
|
-2.47 |
|
-2.47 |
|